Research on at-home diagnostic testing has found that patients frequently misread results, with insufficiently clear instructions identified as a primary contributing factor rather than any problem with the underlying science. That finding came from a single language and a single market, with relatively high health literacy. Now consider the same challenge across 24 EU official languages, or across 20 different Spanish-speaking countries where vocabulary, register, and connotation all vary.

When a user misreads a result, the test has failed its purpose regardless of its clinical accuracy. Confusion drives real decisions.

Diagnostics Is Different

Most medical devices are used by trained professionals in controlled environments. IVDs have moved well beyond that model. Glucose monitors, pregnancy tests, and rapid infectious disease screens are being used at kitchen tables, in bathrooms, and in moments of genuine anxiety.

The IFU is no longer exclusively supporting a clinician. In many cases it is standing in for one, which places significant demands on a translated document.

The Problem With One-Size-Fits-All IFU Translation

It is tempting to treat a single Spanish IFU as covering all Spanish-speaking markets. One language, one document, done. But language does not work that way, and in point-of-care diagnostics the gap between a term’s clinical meaning and its everyday interpretation can matter considerably.

Take positivo as an example. Clinically, it is neutral: a marker has been detected. Outside a clinical setting, positivo carries an optimistic tone, something favourable, something good. If someone reads an STI screening result alone at home, that emotional association matters. The leap from positivo to “this is fine” is a human response, and anticipating it is part of writing a safe IFU.

This is a failure to control context, and in point-of-care diagnostics, context is part of the safety profile.

The Health Literacy Multiplier

Health literacy and general literacy are different things. Someone can be educated, fluent, and still misread a diagnostic result under stress. Add translation friction, regional language variation, and emotional pressure, and the risk becomes structural. Health literacy also starts with the design of the IFU in the source language, before any translation takes place.

Four Questions for IVD Translation Governance

If you are responsible for translation governance in diagnostics, these are worth working through:

1. Do we treat point-of-care diagnostics differently from professional-use products in terms of content, tone, and register?
2. Have translated IFUs been tested with actual lay users in the relevant markets?
3. Who decides on regional language variation, and is that decision documented?
4. Are we checking real comprehension, or linguistic equivalence?

The distinction matters. A translation can be technically accurate and still be misunderstood by the person holding the test in their hands.

What Good Diagnostics Translation Looks Like

Strong translation governance for IVD products includes plain language review alongside clinical translation, usability testing with representative lay users, regional variation assessments where one language spans multiple markets, and terminology management that covers not just what a term means but how it is likely to be understood.

As point-of-care diagnostics expands and regulatory expectations around IFU usability increase, the organisations that invest in this now will be better positioned for both conformity assessment and patient safety outcomes.

How Language Insight Supports IVD and Diagnostics Companies

Language Insight provides specialist translation services for the life sciences sector, with deep expertise in IVD diagnostics, medical device, pharmaceutical, and clinical trial documentation. Our processes are built around ISO 17100 and ISO 13485, combining regulatory expertise with an understanding of how lay users interact with diagnostic materials across markets.

FAQs

Do point-of-care IVDs require a different translation approach?

Yes. Lay users read results alone, often under stress. Translation must go beyond accuracy to consider connotation, plain language, and real-world comprehension, requirements reinforced by IEC 62366.

Can one Spanish IFU work across all Spanish-speaking markets?

Technically yes, but for higher-risk or point-of-care products a regional review of key terms, particularly result terminology, is strongly recommended to avoid connotation mismatches.

What is the difference between linguistic equivalence and comprehension?

Linguistic equivalence means the translation is accurate. Genuine comprehension means the user understands it correctly in context. The gap between the two is where patient safety risk lives.

Does EU IVDR require usability testing of translated IFUs?

Yes. For point-of-care and self-test IVDs, evidence of usability validation, including for translated versions, is expected as part of the technical documentation under EU IVDR and IEC 62366.

Which EU languages are required for IVD documentation?

Labelling and IFUs must be provided in the official language of every member state where the device is placed on the market, each meeting the same accuracy and usability standards as the source.